Clinical Trials

A review of FDA data suggests that women are now better represented in clinical trials.

Publishing negative results might not flatter – but it does matter.

Outsourcing partnerships aim to reduce costs and improve efficiencies, but don't overlook the human elements!

A half-century-old “bet hedging” hypothesis explains the effectiveness of many drug combinations.

We need to face drug attrition to reduce the early-stage risk of drug development.

Are pharma companies willling to open up and share their clinical trial data?

Looking back on wise words from a year of Sitting Down With interviews.

Will AI generate new hypotheses and lead to repurposed failed drug candidates?

Can the microbiome predict the likelihood of chemotherapy side effects?

Drugs often fail , both before and after reaching the market - but why?